Lvm Capital Management LTD Bristol Myers Squibb CO Transaction History
Lvm Capital Management LTD
- $929 Million
- Q4 2024
A detailed history of Lvm Capital Management LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lvm Capital Management LTD holds 14,054 shares of BMY stock, worth $840,710. This represents 0.09% of its overall portfolio holdings.
Number of Shares
14,054
Previous 13,550
3.72%
Holding current value
$840,710
Previous $701,000
13.27%
% of portfolio
0.09%
Previous 0.08%
Shares
15 transactions
Others Institutions Holding BMY
# of Institutions
2,760Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.4 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.49 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.74 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.69 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.61 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $127B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...